Abstract
Patients with cystic fibrosis (CF) have a higher incidence of celiac disease (CD) than the healthy population; however, the actual incidence of coexisting CF and CD is unclear. In this report, we aimed to evaluate the frequency of CD and CF coexistence and to assess the clinical findings of affected patients during follow-up. We conducted a retrospective review of patients with CF to reveal the frequency of CD and also investigated the clinical characteristics and clinical response to gluten-free diet in patients with CD. The incidence of CD in 515 patients with CF was 1.4%. The median age at the time of CF diagnosis was 2 months (1–6 months). CD was diagnosed in six patients with poor weight gain, fatty stools, and low z score for BMI and one patient with poor weight gain despite a high protein and calorie diet and pancreatic enzyme replacement. The median age of CD diagnosis was 8 years (2–12 years). Except for one patient who was recently diagnosed, the other six patients gained weight and their accompanying symptoms resolved after starting a gluten-free diet.
Conclusion: CD should be investigated in patients with CF in the presence of inadequate weight and/or height gain or poor control of malabsorption symptoms despite appropriate and adequate nutritional and enzyme replacement treatment.
What is Known: • CFTR dysfunction may be a risk factor for CD, due to increased intestinal permeability and intestinal inflammation, pancreatic exocrine insufficiency that results in higher antigen load and increased antibodies against to nutritional antigens such as anti-gliadin IgA antibodies. • Although coexistence of CF and CD are rare in the same patient; there is still no consensus on when children with CF should be screened for CD. | |
What is New: • Physicians should consider the investigation of CD in patients with CF, in the presence of inadequate weight and/or height gain or poor control of malabsorption symptoms despite appropriate and adequate nutritional and enzyme replacement treatment. • CFTR dysfunction has been emphasized to develop susceptibility to CD, and patients with CF who have persistent gastrointestinal symptoms despite appropriate and adequate nutritional and enzyme replacement treatment should be screened for CD. |
Similar content being viewed by others
Availability of data and material
The data and materials are available.
Code availability
The code is available for the patients.
Abbreviations
- BECN-1:
-
Beclin-1
- BMI:
-
Body mass index
- CD:
-
Celiac disease
- CF:
-
Cystic fibrosis
- CFTR:
-
Cystic fibrosis transmembrane regulator
- EMA-IgA:
-
Endomysium antibody IgA
- ESPGHAN:
-
European Society for Pediatric Gastroenterology Hepatology and Nutrition
- FEV1:
-
Forced expiratory volume 1
- HLA:
-
Human leukocyte antigen
- NBD-1:
-
Nucleotide-binding domain 1
- SD:
-
Standard deviation
- tTG-IgA:
-
Tissue transglutaminase immunoglobulin Ig A
References
Pohl JF, Judkins J, Meihls S, Lowichik A, Chatfield BA, McDonald CM (2011) Cystic fibrosis and celiac disease: both can occur together. Clin Pediatr 50:1153–1155
Farrell PM (2008) The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 7:450–453
Farrell PM, White TB, Ren CL et al (2017) Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr 181S:S4–S15.e1
Walkowiak J, Blask-Osipa A, Lisowska A, Oralewska B, Pogorzelski A, Cichy W, Sapiejka E, Kowalska M, Korzon M, Szaflarska-Popławska A (2010) Cystic fibrosis is a risk factor for celiac disease. Acta Biochim Pol 57:115–118
Gallegos C, Merkel R (2019) Current evidence in the diagnosis and treatment of children with celiac disease. Gastroenterol Nurs 42(1):41–48
Gujral N, Freeman HJ, Thomson AB (2012) Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 18:6036–6059
Genkova ND, Yankov IV, Bosheva MN, Anavi BL, Grozeva DG, Dzhelepova NG (2013) Cystic fibrosis and celiac disease-multifaceted and similar. Folia Med 55:87–89
Dalgic B, Sari S, Basturk B, Ensari A, Egritas O, Bukulmez A, Baris Z (2011) Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol 106:1565
Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, Shamir R, Troncone R, Auricchio R, Castillejo G, Christensen R, Dolinsek J, Gillett P, Hróbjartsson A, Koltai T, Maki M, Nielsen SM, Popp A, Størdal K, Werkstetter K, Wessels M (2020) European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr 70:141–156
Ramos AT, Figueirêdo MM, Aguiar AP, Almeida Cde G, Mendes PS, Souza EL (2016) Celiac disease and cystic fibrosis: challenges to differential diagnosis. Folia Med 58:141–147
Fluge G, Olesen HV, Gilljam M, Meyer P, Pressler T, Storrösten OT, Karpati F, Hjelte L (2009) Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. J Cyst Fibros 8:198–202
Cohen-Cymberknoh M, Wilschanski M (2009) Concomitant cystic fibrosis and coeliac disease: reminder of an important clinical lesson. BMJ Case Rep 2009:bcr07.2008.0578
Rubio-Tapia A, Murray JA (2008) Liver involvement in celiac disease. Minerva Med 99(6):595–604
Goodchild MC, Nelson R, Anderson CM (1973) Cystic fibrosis and coeliac disease: coexistence in two children. Arch Dis Child 48(9):684–691
Chiaravalloti G, Baracchini A, Rossomando V, Ughi C, Ceccarelli M (1995) Celiac disease and cystic fibrosis: casual association? Minerva Pediatr 47(1–2):23–26
Maiuri L, Villella VR, Raia V, Kroemer G (2019) The gliadin-CFTR connection: new perspectives for the treatment of celiac disease. Ital J Pediatr 45:40
Maiuri L, Villella VR, Piacentini M, Raia V, Kroemer G (2019) Defective proteostasis in celiac disease as a new therapeutic target. Cell Death Dis 10(2):114
Maiuri L, Raia V, Piacentini M, Tosco A, Villella VR, Kroemer G (2019) Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease. Oncotarget. 10:4492–4500
Galluzzi L, Kroemer G (2018) Etiological involvement of CFTR in apparently unrelated human diseases. Mol Cell Oncol 6:1558874
Villella VR, Venerando A, Cozza G et al (2019) A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. EMBO J 38:e100101
Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M, D'Apolito M, Guido S, Masliah E, Spencer B, Quaratino S, Raia V, Ballabio A, Maiuri L (2010) Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12:863–875
Bao F, Green PH, Bhagat G (2012) An update on celiac disease histopathology and the road ahead. Arch Pathol Lab Med 136(7):735–745
WHO AnthroPlus for personal computers manual: software for assessing growth of the world’s children and adolescents. In: Geneva: WHO. 2009.
Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA (2001) Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107:42–45
Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H et al (2007) Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 26:1217–1225
Kupfer SS, Jabri B (2012) Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am 22:639–660
Valleta EA, Mastella G (1989) Incidence of celiac disease in a cystic fibrosis population. Acta Paediatr Scand 78(5):784–785
Ooi CY, Durie PR (2016) Cystic fibrosis from the gastroenterologist’s perspective. Nat Rev Gastroenterol Hepatol 13:175–185
Author information
Authors and Affiliations
Contributions
NE, DAT, HHG, YME, İST, BÖ, BS, EY, DD, UÖ, and NK have made substantial contributions to the design of the work and the interpretation of data for the work.
NE, HHG, DD, UÖ, NK, EY, and İST have revised the manuscript critically for important intellectual content.
NE, DAT, HHG, BÖ, BS, EY, DD, UÖ, and NK have made contributions for final approval of the version to be published.
NE, DAT, HHG, YME, İST, BÖ, BS, EY, DD, UÖ, and NK had the agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Ethics approval
University local ethics committee approved the study (Number: GO 18/473-31).
Consent to participate
Written informed consent was obtained from all patients and their families.
Consent for publication
Written informed consent was obtained for publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Emiralioglu, N., Ademhan Tural, D., Hizarcioglu Gulsen, H. et al. Does cystic fibrosis make susceptible to celiac disease?. Eur J Pediatr 180, 2807–2813 (2021). https://doi.org/10.1007/s00431-021-04011-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04011-4